2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Craig Seaman: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Weight-based Dosing in Hemophilia A rFVIII - Hemophilia | Phase 2 | Terminated | Craig Seaman | 30 | 2015-09-01 | 2020-09-25 |
| Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome Unfractionated heparin - Acute Chest Syndrome, Sickle Cell Disease | Phase 2 | Terminated | Craig Seaman | 7 | 2014-05-01 | 2019-07-16 |
Acute Chest Syndrome (1) · Anemia, Hemolytic (1) · Anemia, Sickle Cell (1) · Hemoglobinopathies (1) · Hemophilia A (1)
F8 protein, human (1) · Factor VIII (1) · Heparin (1) · factor VIII-Fc fusion protein (1)
United States (2)
Craig D Seaman, MD (1) · Margaret Ragni, MD, MPH (1)